Indirect costs of diabetes and its impact on the public finance: the case of Poland

Torój, Andrzej; Mela, Aneta

doi:10.1080/14737167.2017.1366857

Cited by 7 publications

(10 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, a study conducted by the American Diabetes Association (ADA) using data sources from national surveys, Medicare and claims databases for the commercially insured population in the USA found that disease-related disability was the biggest component (42%) of indirect cost 20. Another study in Poland using the national administrative database and human-capital approach found that presenteeism was dominant at 75% of the indirect costs 21. In terms of costs as a percentage of GDP, direct non-medical and indirect cost accounted for 6.3% of Thailand per capita GDP in 20083 and 7.7% of Brazil per capita GDP in 2012 22.…”

Section: Discussionmentioning

confidence: 99%

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

et al. 2020

View full text Add to dashboard Cite

ObjectiveThe prevalence of diabetes in Vietnam has increased from 2.5% in 2007 to 5.5% in 2017, but the burden of direct non-medical and indirect costs is unknown. The objective of this study was to estimate the direct non-medical costs and indirect costs due to type 2 diabetes mellitus (T2DM) and its associated complications among Vietnam Health Insurance System (VHIS) enrollees in Vietnam.DesignThe first phase was a cross-sectional survey of patients with T2DM. In the second phase, data from the previous phase were used to predict direct non-medical costs and presenteeism costs of VHIS enrollees diagnosed with T2DM based on demographic and clinical characteristics in 2017. The human-capital approach was used for the calculation of indirect costs.Setting and participantsThis study recruited 315 patients from a national hospital, a provincial hospital and a district hospital aged 18 or above, diagnosed with T2DM, enrolled in VHIS, and having at least one visit to hospitals between 1 June and 30 July 2018. The VHIS dataset contained 1,395,204 patients with T2DM.Outcome measuresThe direct non-medical costs and presenteeism were collected from the survey. Absenteeism costs were estimated from the VHIS database. Costs of premature mortality were calculated based on the estimates from secondary sources.ResultsThe total direct non-medical and indirect costs were US$239 million in 2017. Direct non-medical costs were US$78 million, whereas indirect costs were US$161 million. Costs of absenteeism, presenteeism and premature mortality corresponded to 17%, 73% and 10% of the indirect costs. Patients incurred annual mean direct non-medical costs of US$56. Annual mean absenteeism and presenteeism costs for patients in working age were US$61 and US$267, respectively.ConclusionsThe impact of T2DM on direct non-medical and indirect costs on diabetes is substantial. Direct non-medical and absenteeism costs were higher in patients with complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

et al. 2020

View full text Add to dashboard Cite

show abstract

“…A study on disease burdens showed that in Poland, the direct costs of diabetes treatment doubled in the 2005–2009 period [ 2 ]. It is estimated that during the years 2012–2014 in Poland, diabetes and its complications were responsible for over 82,000 lost working years, which resulted in over USD 1.9 billion of total indirect costs [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

EQ-5D-5L-based quality of life normative data for patients with self-reported diabetes in Poland

Jankowska

Golicki

2021

PLoS ONE

View full text Add to dashboard Cite

Introduction The new, five-level EQ-5D generic questionnaire (EQ-5D-5L) has never been used among diabetes patients in Poland. Objectives To develop health-related quality of life (HRQoL) norms for patients with self-reported diabetes, based on a large representative sample of the general Polish population, using the EQ-5D-5L. Materials and methods Members of the general public, selected via multistage stratified sampling, filled in the EQ-5D-5L questionnaire and answered a question about the presence of diabetes. We estimated three types of EQ-5D-5L outcomes: limitations within domains, EQ VAS and EQ-5D-5L index. Multiple linear regression was used to examine the relationship between sociodemographic characteristics and HRQoL, both in patients with diabetes and the general population sample. Results Among 2,973 respondents having complete EQ-5D-5L data, 255 subjects (8.6%) self-reported diabetes. Treatment with insulin, other drugs, combination therapy or lack of drug treatment was declared by 22.0%, 48.6%, 5.1% and 24.3% of patients, respectively. Respondents with diabetes had a lower EQ VAS score (18.5 points difference on a 100-points scale) and a lower EQ-5D-5L index score (0.135 difference; scale range: 1.59). The multivariate analysis showed that the factors independently improving the HRQoL in the general population were secondary or higher education, and factors reducing HRQoL were female sex, belonging to an older age group, being treated because of diabetes with insulin, other drugs or combination treatment. Respondents diagnosed with diabetes but not treated with drugs showed a decrease in EQ VAS scores, but not in the EQ-5D-5L index. Conclusions Diabetes leads to HRQoL deterioration in all age groups when compared to matched general population respondents without diabetes. The most significant HRQoL reduction experience older patients with a basic level of education. Obtained EQ-5D-5L normative data may be used in the clinical care of patients with diabetes and health technology assessment of new anti-diabetic drugs.

show abstract

“…The results show that HF in Poland accounted for indirect costs of €871.9 million in 2012 and grew to €945.3 million in 2015, generating an 8.4% increase. The productivity losses due to HF were 25% higher than those associated with breast cancer in Poland [ 18 ] but lower than in the case of diabetes (2 billion US$) [ 23 ] (2014 estimates for all three diseases). The production lost due to HF was an equivalent of 0.212–0.224% of GDP, and no clear time trend was observed; the costs declined in 2012 and 2013 and then increased in 2014.…”

Section: Discussionmentioning

confidence: 99%

Indirect costs and public finance consequences of heart failure in Poland, 2012–2015

Łyszczarz

2018

BMC Public Health

View full text Add to dashboard Cite

BackgroundAs a consequence of unfavourable epidemiological trends and the development of disease management, the economic aspects of heart failure (HF) have become more and more important. The costs of treatment (direct costs) appear to be the most frequently addressed topic in the economic research on HF; however, less is known about productivity losses (indirect costs) and the public finance burden attributable to the disease. Therefore, the aim of this study was to estimate the indirect costs and public finance consequences of HF in Poland in the period 2012–2015.MethodsThe study uses a societal perspective and a prevalence-based top-down approach to estimate the following components of HF indirect costs: absenteeism of the sick and their caregivers, presenteeism of the sick, disability, and premature mortality. The human capital method has been chosen to identify the value of productivity losses attributable to HF and the public finance consequences of the disease. Deterministic sensitivity analysis was performed to assess the robustness of the results.ResultsThe total indirect costs of HF in Poland were €871.9 million in 2012, and they increased to €945.3 million in 2015. In the period investigated, these costs accounted for 0.212–0.224% of GDP, an equivalent of 22.63€–24.59€ per capita. Mortality proved to be the main driver of productivity losses, with 59.3–63.4% of the total costs depending on year, followed by presenteeism (21.1–22.5%), disability (11.1–14.2%) and the sick’s absenteeism (3.3–4.0%). The cost of caregivers’ absenteeism was unimportant. The social insurance expenditure for benefits associated with HF accounted for €40.7 million in 2012 and €45.6 million in 2015 (0.56–0.59% expenditure for all diseases). The potential public revenue losses associated with HF were €262.7–€287.9 million. Sensitivity analysis showed that the costs varied by − 12.1% to + 28.8% depending on the model parameter values.ConclusionHF is a substantial burden on the economy and public finance in Poland. By confronting the disease more effectively, the length and quality of life for those affected by HF could be improved, but society as a whole could also benefit from the increased economic output.

show abstract

Indirect costs of diabetes and its impact on the public finance: the case of Poland

Abstract: Estimated indirect cost of diabetes can be a useful input for health technology analyses of drugs or economic impact assessments of public health programmes.

Cited by 7 publications

References 8 publications

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

EQ-5D-5L-based quality of life normative data for patients with self-reported diabetes in Poland

Indirect costs and public finance consequences of heart failure in Poland, 2012–2015

Contact Info

Product

Resources

About